The life-sciences company expects its capsules and health business to return to growth in 2025, after sales and earnings fell last year on slower demand.

Kobayashi Pharmaceutical Co. on Feb. 10 posted its first full-year profit decline since going public in 1999 as the health ...

Fact checked by Nick Blackmer The price of over-the-counter pain medicines, antibiotics, and supplements may spike following ...